NCT06710756 2026-01-16Lead-212 PSV359 Therapy for Patients With Solid TumorsPerspective TherapeuticsPhase 1/2 Recruiting112 enrolled
NCT03556228 2025-12-11VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaVM Oncology, LLCPhase 1/2 Recruiting242 enrolled
NCT05944237 2025-06-08HTL0039732 in Participants With Advanced Solid TumoursCancer Research UKPhase 1/2 Recruiting150 enrolled